Search

Your search keyword '"Adriano, Chiò"' showing total 470 results

Search Constraints

Start Over You searched for: Author "Adriano, Chiò" Remove constraint Author: "Adriano, Chiò"
470 results on '"Adriano, Chiò"'

Search Results

2. Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2024.

Catalog

Books, media, physical & digital resources

3. Overview of iDPP@CLEF 2024: The Intelligent Disease Progression Prediction Challenge.

5. Resting‐state fMRI functional connectome of C9orf72 mutation status

7. The role of peripheral immunity in ALS: a population‐based study

8. Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2023.

9. Overview of iDPP@CLEF 2023: The Intelligent Disease Progression Prediction Challenge.

13. Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial

14. Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2022.

15. Overview of iDPP@CLEF 2022: The Intelligent Disease Progression Prediction Challenge.

18. Case report: Atypical Parkinsonism following SARS-CoV-2 infection

19. Deep learning methods to predict amyotrophic lateral sclerosis disease progression

20. Calculated Maximal Volume Ventilation (cMVV) as a Marker of Early Respiratory Failure in Amyotrophic Lateral Sclerosis (ALS)

21. The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases

22. Serum chloride as a respiratory failure marker in amyotrophic lateral sclerosis

23. Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis

24. C9orf72 ALS mutation carriers show extensive cortical and subcortical damage compared to matched wild-type ALS patients

25. Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol

26. Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis

27. Profiling morphologic MRI features of motor neuron disease caused by TARDBP mutations

28. A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients

29. Exploiting mutual information for the imputation of static and dynamic mixed-type clinical data with an adaptive k-nearest neighbours approach

30. Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images

31. Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review.

32. Unraveling the complex interplay between genes, environment, and climate in ALS

33. The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations

34. A Dynamic Bayesian Network model for the simulation of Amyotrophic Lateral Sclerosis progression

37. PRECISION ALS—an integrated pan European patient data platform for ALS

39. The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice

41. Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions

42. Age-related penetrance of the C9orf72 repeat expansion

43. Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis

44. Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients

45. Multimodal structural MRI in the diagnosis of motor neuron diseases

46. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040

48. The Characteristics of Cognitive Impairment in ALS Patients Depend on the Lateralization of Motor Damage

49. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis

50. The Role of CHI3L1 Plasmatic Levels in Amyotrophic Lateral Sclerosis